文献速递系统性红斑狼疮

狼疮-克鲁塞斯肾炎方案在不同预后分组中的疗效:倾向评分与聚类分析

Efficacy of the Lupus-Cruces Nephritis protocol in different prognostic groups: a propensity score and cluster analysis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究基于狼疮-克鲁塞斯等三个队列147例狼疮肾炎患者的观察性比较数据,评估狼疮-克鲁塞斯肾炎(LCN)方案与标准治疗(SOC)达成完全肾脏缓解(CRR)的差异。LCN组12个月CRR为85%(40/47),SOC组为44%(44/100),各预后亚组及三个临床聚类中LCN方案均与更高CRR相关。

要点

  • LCN方案12个月CRR达85%,标准治疗为44%。
  • 倾向评分校正后各预后亚组结果一致。
  • 三个聚类中LCN方案均与更高CRR相关。

核心结论

  • LCN方案在不同预后亚组和临床聚类中达成CRR均优于标准治疗方案。

研究设计与样本

  • 观察性比较研究,纳入狼疮-克鲁塞斯、历史狼疮-克鲁塞斯和狼疮-波尔多三个队列共147例患者。
  • 采用双向聚类分析识别三个临床聚类,并进行多变量倾向评分校正分析和Cox比例风险分析。

主要发现

  • LCN组12个月CRR为85%(40/47),SOC组为44%(44/100)。
  • 倾向评分校正逻辑回归在各亚组中确认上述结果。
  • C1聚类HR 10.7(95%CI 1.65-69.6,P=0.013),C2聚类HR 2.2(95%CI 1.16-4.1,P=0.016),C3聚类HR 6.1(95%CI 2.99-12.51,P<0.001)。

临床怎么用

  • 在狼疮肾炎不同预后亚组和临床聚类中,可考虑采用LCN方案以提高完全肾脏缓解率。

局限性

  • 本研究为观察性比较研究,非随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the efficacy of the Lupus-Cruces Nephritis (LCN) protocol vs standard of care (SOC) in achieving complete vrenal response (CRR) among different subpopulations and clinical clusters of patients with LN. METHODS: This was an observational comparative study with clinical care data of patients from the Lupus-Cruces, historic Lupus-Cruces and Lupus-Bordeaux cohorts. Different prognostic factors were obtained from previous studies and analysed in both LCN and SOC groups. Three different clinical clusters of patients were identified using a two-way clustering analysis. A multivariate propensity score (PS) adjusted analysis and Cox proportional hazards analysis were performed comparing both therapeutic schemes in the different identified subpopulations and clusters. RESULTS: Within the cohort of 147 patients, those receiving the LCN protocol (40/47, 85%) were more likely to achieve CRR at 12 months than patients receiving the SOC (44/100, 44%). This was consistent across all prognostic subpopulations. The PS-adjusted logistic regression by subgroups confirmed these results. Three different clusters (named C1, C2 and C3) were identified. Both the univariate and the PS-adjusted Cox regression analysis for CRR at any time confirmed the higher likelihood of achieving CRR of patients treated with the LCN protocol in the three clusters: C1, hazard ratio (HR) 10.7 (95% CI 1.65-69.6, P = 0.013); C2, HR 2.2 (95% CI 1.16-4.1, P = 0.016); C3, HR 6.1 (95% CI 2.99-12.51, P < 0.001). CONCLUSION: The LCN protocol was superior to the SOC schemes in achieving CRR in patients with LN across different subpopulations and clinical clusters.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ruiz-Irastorza G, Marín-García B, Dueña-Bartolomé L, et al. Efficacy of the Lupus-Cruces Nephritis protocol in different prognostic groups: a propensity score and cluster analysis. Rheumatology (Oxford). 2026. PMID: 42018741. doi:10.1093/rheumatology/keag214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。